Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
InhaleRx Limited ( (AU:NX1) ) just unveiled an update.
Nexalis Therapeutics has scheduled its 2026 Annual General Meeting for 4:00 p.m. AEST on Friday, 29 May 2026, to be conducted as an online-only event where shareholders can watch, listen, ask questions and vote remotely. The company is encouraging shareholders to pre-register for the Zoom webinar, lodge proxy votes by 4:00 p.m. AEST on Wednesday, 27 May 2026, and access the Notice of Meeting electronically via the share registry or ASX page in line with updated corporate meeting regulations.
More about InhaleRx Limited
Nexalis Therapeutics Ltd (ASX: NX1) is an Australia-based biotechnology company operating in the therapeutics sector. The company is listed on the Australian Securities Exchange and has a shareholder base that engages with the company through annual general meetings and online investor communications.
Average Trading Volume: 164,123
Technical Sentiment Signal: Sell
Current Market Cap: A$5.82M
For a thorough assessment of NX1 stock, go to TipRanks’ Stock Analysis page.